Pillcheck recommendations are based on PGx prescribing guidelines by the Clinical Pharmacogenetics Implementation Consortium (CPIC) and drug warning labels from regulatory bodies (see the complete list). Recommendations apply to various areas, including psychiatry, cardiology, gastroenterology, oncology, neurology, pain management, rheumatology, transplant, and urology.

The Pillcheck panel of genetic markers is optimized for the ethnically diverse population in North America. It includes the Tier 1 and Tier 2 alleles affecting drug metabolism, transport and response, which are recommended by the American Association for Molecular Pathology. Genetic testing is performed in Canada by an accredited laboratory. See the biomarkers tested.

Pillcheck includes a medication review by a clinical pharmacist who provides therapy recommendations based on your patient’s prior medication experience, predicted drug metabolism and response, and concomitant medications. See a sample Pharmacist Opinion Letter.

As the referring healthcare provider, you access the interactive results viewer via the secure Pillcheck Portal. Pillcheck regularly updates each client’s report according to new guidelines and expanded drug labels. The pharmacist’s medication review is dated, signed by the licensed pharmacist, and can be downloaded as a PDF to be attached to the patient’s record. See a demo.